retinitis

(redirected from retinitis pigmentosa)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
Legend
Synonym
Antonym
Related
  • noun

Words related to retinitis

inflammation of the retina

References in periodicals archive ?
PIONEER is a first-in-man, multi-center, open label dose-escalation study to evaluate the safety and tolerability of GS030 in subjects affected by end-stage non-syndromic retinitis pigmentosa with vision not better than "counting fingers.
This family showing a clear pattern of early onset retinitis pigmentosa was checked through linkage analysis against the known genes by using the STS markers.
Table: Identified Retinitis pigmentosa genetic mutations in South Asia.
Retinitis Pigmentosa (Retinitis) - Therapeutics under Development by Companies 11
I took part in the trial mainly to help future generations living with retinitis pigmentosa.
Types of genetic eye disorders had 10 attributes; Strabismus, cataract, extreme myopia, anophthalmia, microphthalmia, astigmatism and nystagmus, keratoconus, glaucoma and retinitis pigmentosa.
Retinitis Pigmentosa (RP) is a group of rare, inherited genetic disorders characterized by progressive peripheral vision loss and night vision difficulties followed by eventual central vision loss and blindness in many cases.
The report provides a snapshot of the global therapeutic landscape of Retinitis Pigmentosa (Retinitis)
Association of antiretinal antibodies and cystoid macular edema in retinitis pigmentosa.
The X-linked form of retinitis pigmentosa is an ideal candidate for a precision medicine approach because a common mutation accounts for 90 percent cases.
From this chart review, 103 individuals who had been diagnosed as having retinitis pigmentosa were recruited for the present study.
The Company is currently targeting the orphan ocular indication retinitis pigmentosa (RP) for first-in-man studies, expected to start in 2016.
Spark Therapeutics and Genable Technologies have entered into a collaboration agreement for Genable's lead therapeutic to treat rhodopsin-linked autosomal dominant retinitis pigmentosa (RHO adRP), GT038.
The three young New Zealanders have retinitis pigmentosa -- a progressive disorder that eventually deteriorates vision over the course of decades.
INTRODUCTION: Laurence-Moon-Bardet-Biedl syndrome (LMBBS) is a rare, genetically heterogeneous, autosomal recessive disorder characterized by early onset retinitis pigmentosa, post axial polydactyly, central obesity, mental retardation, hypogonadism and kidney structural abnormalities or functional impairment.